New strategies to increase the uptake of these proven breast cancer risk-reduction interventions in general clinical practice are needed.
Tomoko Tagawa, MD
Advertisement
Articles by Tomoko Tagawa, MD
Advertisement
Latest Updated Articles
Breast Cancer Chemoprevention: Targeting the Estrogen ReceptorPublished: January 31st 2016 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma
3
2025 Data Across Gynecologic, Lung, and Hematologic Cancers Reshape Treatment Landscapes
4
Third NDA for Rivoceranib/Camrelizumab Is Resubmitted to FDA for Unresectable HCC
5